Call for abstracts
Abstract Submission Period
- October 2 (Thu) –
-
November 27 (Thu), 2025
December 1 (Mon), by noon(JST)
*In response to requests from our members, the abstract submission deadline has been extended.
Please note that no further extensions will be granted.
Please ensure that you complete your submission within the specified period.
The call for abstracts is closed. Thank you for your participation.
Submission Guidelines
[Abstract Categories]
Please select one category each from (A), (B), and (C) below.
Example 1
“Investigation of Exacerbating Factors Leading to Acute Liver Failure in Acute Hepatitis B”
Category A: 1. Clinical
Category B: 01. Hepatitis B
Category C: 21. GWAS & Genomics
Example 2
“Evaluation of the Effect of Drug A on Sarcopenia Improvement Using a Mouse Model of Liver Cirrhosis”
Category A: 2. Basic
Category B: 32. Sarcopenia & Frailty in Liver Diseases
Category C: 44. Drug Discovery & Preclinical Development
Category (A)
1. Clinical
2. Basic
Category (B)
01.Hepatitis B
02.Hepatitis C
03.Viral Hepatitis（non-B/C）
- 04.
- Acute Hepatitis / Acute Liver Failure
05.ACLF / Acute-on-chronic Liver Failure
06.Primary Liver Cancer
07.Metastatic Liver Cancer
08.Other Liver Tumors
09.Cholangiocarcinoma
- 10.
- Benign Biliary Diseases
- 11.
- Pancreatic Diseases
- 12.
- Alcohol-Related Liver Disease（ALD/MetALD）
- 13.
- Steatotic Liver Disease（SLD/MASLD/MASH）
14.Autoimmune Hepatitis
15.Primary Biliary Cholangitis（PBC）
- 16.
- Primary Sclerosing Cholangitis（PSC）
17.IBD-related Liver Diseases
18.Budd–Chiari Syndrome
- 19.
- Biliary Atresia / Alagille Syndrome
20.Drug-Induced Liver Injury（DILI）
- 21.
- Immune-Related Adverse Events（irAEs/imAEs）
- 22.
- Metabolic / Congenital Liver Diseases
23.Cystic Liver Diseases
- 24.
- Pediatric Liver Diseases / Transitional Care
25.Liver Cirrhosis / Liver Fibrosis
- 26.
- Complications of Cirrhosis / Chronic Liver Failure
- 27.
- Portal Hypertension / Varices
- 28.
- Intrahepatic Lithiasis / Cholelithiasis
- 29.
- Rare & Undiagnosed Liver Diseases
30.Geriatric Hepatology
31.Pregnancy & Liver Diseases
- 32.
- Sarcopenia & Frailty in Liver Diseases
33.Sex & Gender Differences
34.Liver Abscess, Infectious Diseases
- 35.
- Systemic Disease-Related Liver Diseases
- 36.
- Dermatologic Manifestations of Liver Diseases
37.Renal Manifestations of Liver Diseases
- 38.
- Cardiovascular Manifestations of Liver Diseases
- 39.
- Pulmonary Manifestations of Liver Diseases
- 40.
- Bleeding Tendency, Coagulation Disorders & Portal Vein Thrombosis in Liver Diseases
- 41.
- MASH & Chronic Liver Diseases with Extrahepatic Cancer Risk
- 42.
- SOS/VOD / Sinusoidal Obstruction Syndrome & Veno-Occlusive Disease
- 43.
- Other
Category (C)
- [Basic and Translational Research]
- 01.
- Hepatocyte Differentiation / Regeneration / Stem Cells
- 02.
- Tissue Engineering, Artificial Liver & Liver Regeneration
- 03.
- Organ-on-Chip & Microphysiological Systems
- 04.
- Molecular Basis of Anti-fibrotic Therapies
- 05.
- Vascular Biology & Portal Hypertension
- 06.
- Parenchymal / Non-parenchymal Liver Cells
- 07.
- Cellular Senescence & Aging-Related Liver Diseases
- 08.
- Cell Death（Apoptosis, Necroptosis, Ferroptosis, Autophagy）
- 09.
- Molecular Carcinogenesis & Cancer Prevention Strategies
- 10.
- Extracellular Vesicles / MSCs
- 11.
- iPS Cells
- 12.
- Bile Acids / Cholestasis / Biliary Injury
- 13.
- Oxidative Stress / ER Stress
- 14.
- Organ Crosstalk（Heart, Lung, Kidney, etc.）
- 15.
- Gut-Liver Axis
- 16.
- Microbiota
- 17.
- Multi-omics & Spatial Transcriptomics
- 18.
- Disease Models / Organoids
- 19.
- Immunology
- 20.
- Metabolism
- 21.
- GWAS & Genomics
- 22.
- Infectious Diseases
- 23.
- Virology
- 24.
- Surgery & Procedures
- 25.
- AI Diagnostic Tools
- 26.
- Digital Biomarkers
- [Diagnosis]
- 27.
- Imaging Diagnosis
- 28.
- Functional Imaging
- 29.
- Liver Stiffness Measurement
- 30.
- HVPG Measurement
- 31.
- Angiographic Diagnosis
- 32.
- Pathological Diagnosis（Conventional Pathology）
- 33.
- Digital Pathology（AI & Remote Diagnostics）
- 34.
- Liquid Biopsy / Biomarkers
- 35.
- Molecular & Multi-omics Diagnostics
- 36.
- Diagnostic Methods for Hepatic Encephalopathy
- 37.
- AI Diagnostic Tools
- 38.
- Non-Invasive Liver Disease Assessment
- 39.
- Diagnostic Methods for Hepatic Encephalopathy
- 40.
- Diagnostic Evaluation of Dermatologic, Renal, Cardiovascular & Coagulation Disorders
- 41.
- Extrahepatic Cancer Screening in Chronic Liver Diseases
- 42.
- Diagnostic Methods for SOS/VOD
- 43.
- Diagnostic Evaluation of Pulmonary & Portal Vein Disorders
- [Therapy]
- 44.
- Drug Discovery & Preclinical Development
- 45.
- Antiviral Therapy
- 46.
- Anti-fibrotic Therapies for Liver Cirrhosis
- 47.
- Recompensation in Chronic Liver Disease
- 48.
- Carcinogenesis & Cancer Prevention
- 49.
- Therapies for Portal Hypertension
- 50.
- Therapy for Portal Vein Thrombosis
- 51.
- Therapy for SOS/VOD
- 52.
- Therapies for Complications of Cirrhosis
- 53.
- Endoscopic Therapy（Endo-Hepatology）
- 54.
- Local Therapies（Ablation, TACE, Radiotherapy）
- 55.
- Molecular Targeted Therapy for Liver Cancer
- 56.
- Antibody-based Therapy for Liver Cancer
- 57.
- Immune Checkpoint Inhibitors
- 58.
- Combination Therapy
- 59.
- Interventional Radiology (IVR) Therapies （TACE, TARE, HAIC, BRTO, TIPS）
- 60.
- Radiation & Heavy Ion Radiotherapy
- 61.
- Surgical Treatments
- 62.
- Liver Transplantation
- 63.
- Cell-based Therapy
- 64.
- Gene Therapy
- 65.
- Regenerative Medicine
- 66.
- Precision Therapeutics
- 67.
- Addiction Medicine （Alcohol & Substance Use Disorders, PWUD/PWID）
- 68.
- Exercise Therapy
- 69.
- Nutritional Therapy
- 70.
- Rehabilitation （Lifestyle, Frailty, Robot-assisted e.g., HAL, Home-based, Palliative）
- 71.
- Home-based Palliative Care & Support
- 72.
- Digital Health & Therapeutic Apps
- 73.
- Real-world Data & Outcomes Research
- 74.
- Extracorporeal Liver Support & Blood Purification Therapies （incl. On-line HDF, MARS）
- 75.
- Therapy for Hepatic Encephalopathy
- [Clinical Systems and Healthcare Structure]
- 76.
- Public Health, Hepatitis Control & Hepatitis Coordinator
- 77.
- Healthcare Policy & System Design
- 78.
- Health Economics & Insurance
- 79.
- Registry & Big Data Research
- 80.
- Ethics & COI Management
- 81.
- Home-based & Palliative Care
- 82.
- Patient Centricity
- 83.
- Network & ICT Integration in Healthcare
- 84.
- International Collaboration & Joint Research
- 85.
- Patient Education & Public Engagement
- 86.
- Patient Advocacy & Partnerships
- 87.
- Training for Young Physicians & Researchers
- 88.
- Medical Student & Resident Education
- 89.
- International Exchange & Fellowship Programs
- 90.
- Interprofessional Education（IPE）
- 91.
- AI Literacy in Hepatology
- 92.
- Leadership & Management in Medicine
- 93.
- Patient-Centered Care Education
- 94.
- Career Support & Professional Development
- 95.
- Other
Necessary Information on an Abstract
- Name of author
- Name of co-author(s)
- Institutional affiliation(s)
- Title of abstract; less than 20 words
-
Abstract; less than 300 words
*Figures and tables cannot be uploaded.
Submission and Acceptance Process
-
Please download the Abstract Submission Form below and send it to the Secretariat of the 62nd Annual Meeting of the Japan Society of Hepatology at
jsh62-abs@congre.co.jp - If you do not receive an acknowledgment email within 48 hours after submission (excluding weekends and holidays), please contact the Secretariat.
- The acceptance of submitted abstracts and the allocation to Oral or Mini Oral sessions will be determined by the Abstract Review Committee after careful evaluation.
Notification of acceptance will be sent by e-mail around late March.
Contact for Abstract Submission
Secretariat, The 62nd Annual Meeting of the Japan Society of Hepatology
c/o Congress Corporation
jsh62-abs@congre.co.jp